The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.

BACKGROUND AND OBJECTIVES: Prostate cancer (PCa) is one of the most common cancers and leading cause of cancer-related deaths in men. Mass screening has been carried out since the 1990s using prostate-specific antigen (PSA) levels in the serum as a PCa biomarker. However, although PSA is an excellen...

Full description

Bibliographic Details
Main Authors: Kenji Nakayama, Takahiro Inoue, Sadanori Sekiya, Naoki Terada, Yu Miyazaki, Takayuki Goto, Shigeki Kajihara, Shin-Ichiro Kawabata, Shinichi Iwamoto, Kuniko Ikawa, Junko Oosaga, Hiroaki Tsuji, Koichi Tanaka, Osamu Ogawa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4169392?pdf=render